Research programme: skin disorder therapies - SunTen Phytotech

Drug Profile

Research programme: skin disorder therapies - SunTen Phytotech

Alternative Names: STD 06

Latest Information Update: 04 Feb 2011

Price : $50

At a glance

  • Originator SunTen Phytotech
  • Developer Lumosa Therapeutics
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes - Skin disorders

Highest Development Phases

  • Preclinical Dermatitis; Wounds

Most Recent Events

  • 04 Feb 2011 Research programme: skin disorder therapies - SunTen Phytotech is available for licensing as of 19 May 2008. http://www.stpt.com.tw/eng
  • 19 May 2008 This programme is available for licensing (http://www.stpt.com)
  • 19 May 2008 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top